Arcadia Biosciences, Inc.
RKDA
$3.60
$0.020.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.30M | 1.46M | 1.20M | 1.22M | 1.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.30M | 1.46M | 1.20M | 1.22M | 1.54M |
| Cost of Revenue | 884.00K | 833.00K | 682.00K | 695.00K | 1.06M |
| Gross Profit | 418.00K | 622.00K | 518.00K | 521.00K | 481.00K |
| SG&A Expenses | 1.57M | 2.12M | 1.74M | 2.65M | 2.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.45M | 2.96M | 2.42M | 3.34M | 3.30M |
| Operating Income | -1.15M | -1.50M | -1.22M | -2.13M | -1.76M |
| Income Before Tax | 856.00K | -4.46M | 2.60M | -4.03M | -1.18M |
| Income Tax Expenses | -- | -- | -- | 8.00K | -- |
| Earnings from Continuing Operations | 856.00K | -4.46M | 2.60M | -4.04M | -1.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -27.00K | -430.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 856.00K | -4.46M | 2.60M | -4.06M | -1.61M |
| EBIT | -1.15M | -1.50M | -1.22M | -2.13M | -1.76M |
| EBITDA | -1.15M | -1.49M | -1.21M | -2.10M | -1.75M |
| EPS Basic | 0.63 | -3.26 | 1.90 | -2.98 | -1.18 |
| Normalized Basic EPS | 0.39 | -2.50 | 0.39 | -1.77 | -0.54 |
| EPS Diluted | 0.62 | -3.26 | 1.90 | -2.98 | -1.19 |
| Normalized Diluted EPS | 0.39 | -1.31 | 0.39 | -1.77 | -0.54 |
| Average Basic Shares Outstanding | 1.37M | 1.37M | 1.37M | 1.37M | 1.36M |
| Average Diluted Shares Outstanding | 1.37M | 2.60M | 1.37M | 1.37M | 1.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |